Treatment of dementia with bosutinib: An open-label study of a tyrosine kinase inhibitor

Kennedy D. Mahdavi, Sheldon E. Jordan, Hannah R. Barrows, Maša Pravdic, Barshen Habelhah, Natalie E. Nicodemus, Robin B. Blades, Jessica J. Iovine, Sergio A. Becerra, Rachel A. Steiner, Marisa Chang, Santosh Kesari, Alexander Bystritsky, Ed O'Connor, Hyman Gross, F. Scott Pereles, Mike Whitney, Taylor Kuhn. (2020). Neurology.

Previous
Previous

Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV

Next
Next

Neurogenic Thoracic Outlet Syndrome and other Forms of Cervical Brachial Syndrome Treated with Plasma Concentrate Enriched for Alpha 2 Macroglobulin